Stay updated on IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.

Latest updates to the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page
- Check5 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRecord history shows a new revision v3.3.2 was added and revision v3.2.0 was removed from the NCT02676869 record, indicating a minor maintenance/version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedThe government operating status notice about funding has been removed. All other study history content remains unchanged.SummaryDifference0.7%

- Check55 days agoChange DetectedThe Record History shows a minor update to the version list, while core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check84 days agoChange DetectedAdded a government funding notice and an updated software version (v3.2.0), removing the old v3.1.0; this primarily updates the page’s operating status guidance and versioning.SummaryDifference12%

- Check91 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.